The Office of Cannabis Management says it will not add any additional delivery methods to the medical cannabis program in 2025. The office defines delivery method as the form in which a medication is taken.
Three petitions to expand the delivery method to include dry powder inhalation, infused flower, and concentrates were presented to the office for review before the state's Dec. 1 deadline. The Office of Cannabis Management says they evaluated the petitions based on a review of scientific evidence and potential health and safety impacts for patients.
The office says dry powder inhalers are a method of consuming dry powder containing THC, CBD, and/or any other cannabinoids. Medicinal cannabis inhalers are similar to inhalers used for asthma.
Due to federal limitations on cannabis research, the office passed on inhalers because of the limited peer-reviewed studies that show this method is safe for medical cannabis patients, says the Office of Cannabis Management.
Read more at CBS News